Today’s issue of WorkCompRecap features the recent announcement from Injured Workers’ Pharmacy (IWP) of the release of their first industry drug trends report, Work Comp Pharmacy: A Front Line Perspective.
IWP noted that since they call themselves “the patient advocate pharmacy”, they would issue a report that focuses less on the drugs themselves and more on how greater involvement of clinical pharmacists on behalf of patients can impact treatment and prescribing patterns. The report also highlights a 7% decrease in the use of narcotic analgesics accompanied by a 6% increase in Non-narcotic Analgesics, Anti-Inflammatory or Antipyretics, which it points to as a result of IWP’s efforts to reduce overall opioid use, which are also highlighted in additional stats on reductions of MMEs, and reductions in the number of patients starting opioid, benzodiazepine and carisoprodol (OBC) combinations.
Find out more by clicking here!